About 100 reports

EXECUTIVE SUMMARY ##.

  • Obesity
  • Pathology
  • Surgical Equipment
  • World
  • Market Shares
  • Anti-obesity drugs Industry
  • Anti-obesity Drugs Imports and Exports

ANTI-OBESITY DRUGS PRODUCER DIRECTORY This is Herbalife' s one and only manufacturing base apart from the one in America.

  • Obesity
  • China
  • Demand
  • Abbott Laboratories, Inc.
  • Shanghai Jahwa United Co., Ltd.

Factors such as the increase in childhood obesity incidence and the use of implantable neuroregulatory devices for treating obesity, will provide considerable growth opportunities to anti-obesity drugs manufactures.

  • Obesity
  • Pathology
  • World
  • Anti-obesity drugs Industry
  • Anti-Obesity Drug Industry Structure

ANTI-OBESITY DRUGS PRODUCER DIRECTORY This is Herbalife' s one and only manufacturing base apart from the one in America.

  • Obesity
  • China
  • Abbott Laboratories, Inc.
  • Beijing Outsell Health Product Development Co., Ltd.
  • Shanghai Jahwa United Co., Ltd.
  • Anti-obesity Drugs Imports
  • Other Anti-obesity Drugs

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for anti-obesity drugs in China is growing rapidly.

  • Obesity
  • Pathology
  • China
  • Demand
  • Abbott Laboratories, Inc.

GLP-## receptor agonists ##. ##. ##. ##.

  • Obesity
  • Pathology
  • World
  • Demand
  • Forecast

Global Anti-Obesity Drugs Market Forecast 2018-2028 ##.

  • Obesity
  • Pathology
  • World
  • Market Shares
  • Obesity 2021
  • Obesity is here to stay

While some ##% of children and adolescents aged ##-## were obese in 1975, this had risen to ##% of girls and ##% of boys in 2016.

  • Obesity
  • United Kingdom
  • United States
  • World
  • Demand
  • 2 Obesity: Executive Summary
  • 4.3 SUSTAINED INNOVATION IN OBESITY

Table ##: Nutritional status Obesity can be classified based on different BMI.

  • Obesity
  • Pathology
  • World
  • Promising Drugs in Development for Obesity
  • Obesity Development Pipeline, by Phase

Report Code: GDHC##CL Published: October 2018 Obesity: Competitive Landscape to 2026 Healthcare TABLE OF CONTENTS ##.

  • Obesity
  • United States
  • Market Competition
  • Eisai Co., Ltd.
  • Novo Nordisk Group

The approved drugs in the obesity space target gastric lipase, dopamine, norepinephrine (noradrenaline), dopamine reuptake, norepinephrine (noradrenaline) reuptake/ transporter, opioid receptors, GABA-A receptor, serotonin ##-HT##C receptor, and glucagon-like peptide-## (GLP-

  • Obesity
  • Pathology
  • European Union

##.

  • Obesity
  • Pathology
  • World
  • Market Size

Anti-Obesity Prescription Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026 ##.

  • Obesity
  • World
  • Demand
  • Market Shares
  • Market Size
  • Obesity
  • Obesity Rising

In 2017, hard discounter Dia (Argentina) launched ##% juice in one flavour and pack size.

  • Obesity
  • Pathology
  • Chile
  • Latin America
  • Demand

##.

  • Obesity
  • Pathology
  • World
  • Market Size
  • Japan Obesity Prevalence Rate, 2016
  • Africa Obesity Prevalence Rate, 2016

THE DETAILS ##.

  • Obesity
  • World
  • Abbott Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • LifeScan, Inc.

Obesity Surgery Devices Market by Procedure, by Type, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023 Chapter ##.

  • Obesity
  • APAC
  • World
  • Forecast
  • Market Size

North America alone is expected to account for ##/ ##rd of the global obesity management market North America is forecast to account for more than ##/ ##rd revenue share of the global obesity management market by 2017 and it should gain a substantial ## BPS b

  • Obesity
  • Pathology
  • World
  • Forecast

Global Obesity Epidemiology and Patient Flow Analysis - 2017 ##.

  • Obesity
  • Pathology
  • United States
  • World
  • Forecast
  • OBESITY
  • OBESITY

SUPPLIER POWER - LOW ##.

  • Obesity
  • World
  • OptiBiotix Health plc
  • PureTech LLC
  • Ritter Pharmaceuticals, Inc.

Biomarker-based research may also open novel paradigms for drug discovery and development obesity and diabetes disorders.

  • Biomarker
  • Genomics Proteomics And Enabling Technology
  • Obesity
  • World
  • Forecast
  • A) Obesity prevalence
  • Diabetes an d obesity

Obesity Research; ##(##): ##-## Sands AT, et al. (2015).

  • Obesity
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Oceania Obesity Prevalence, 1990-2014 (% of Adults Aged 18+ Years)
  • Global Obesity Prevalence,1990- 2014 (% of Adults Aged 18+ Years)

Table ##.

  • Obesity
  • World
  • ConAgra Foods, Inc.
  • GlaxoSmithKline plc
  • Unilever PLC
  • ADULTS WITH OBESITY WORLDWIDE
  • 8.1.2 RISING NUMBER OF OBESITY CASES

OBESITY IS ONE OF THE MAJOR RISK FACTORS FOR INFERTILITY.

  • Hospital
  • Obesity
  • World
  • Market Size
  • Merck & Co., Inc.
  • Global Obesity and Overweight Population
  • Obesity was recognized as a global epidemic by the World Health Organisation in 1997.

DIABETES IS ONE OF THE LEADING CAUSES OF OBESITY.

  • Obesity
  • World
  • Demand
  • Forecast
  • Market Size

Europe Obesity Epidemiology and Patient Flow Analysis - 2017 ##.

  • Obesity
  • Europe
  • France
  • Germany
  • Forecast
  • GLOBAL OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 7.6.2 Global Obesity Market Revenue and Forecasts to 2025 (US$ Mn)

TABLE ##. ##.

  • Obesity
  • World
  • Forecast
  • Market Size
  • MicroBiome Therapeutics LLC
  • Increasing focus of governments to reduce obesity in developed countries
  • MARKET DRIVERS

According to the NHS, if it remains same, by 2034, one in every ten APAC Factor obese.

  • Hospital
  • Obesity
  • World
  • Forecast
  • Medtronic, Inc.
  • Product Approvals
  • FRANCE: BARIATRIC SURGERY DEVICES MARKET, BY PROCEDURE, 2016-2023 (USD MILLION)

IT ALSO STATED THAT ONE IN EVERY FOUR AUSTRALIAN CHILDREN WERE OVERWEIGHT OR OBESE.

  • Obesity
  • North America
  • United States
  • Ethicon, Inc.
  • Intuitive Surgical, Inc.

Obesity Drugs and Therapies: Technologies and Global Markets OBESITY DRUGS AND THERAPIES: TECHNOLOGIES AND GLOBAL MARKETS CHAPTER ## INTRODUCTION ## STUDY GOAL AND OBJECTIVES ## SCOPE OF REPORT ## INTENDED AUDIENCE ## METHODOLOGY ## INFORMATION SOURCES ## ANALYST' S CREDENTIA

  • Obesity
  • Pathology
  • Therapy
  • World
  • Market Size